Professional Documents
Culture Documents
safety problems
Mary R Couper
Quality Assurance and Safety of Medicines
– large population
– all medicines
– hospital and out-patient care
– long perspective
– patient analyses possible
– inexpensive
Underreporting
No denominator data
Ref. Drug Safety 2006: An assessment of the publicly disseminated evidence of safety used in
decisions to withdraw medicinal products from the UK and US markets. Clarke A, Deeks JJ,
Shakir SA.
Followed up by
– Stimulated Passive Reporting &/or
– Spontaneous reporting
(‘Hot pursuit’)
Interactions with
– Other medicines
– Complementary and alternative medicines
– Foods
Hypothesis generation
Exposed Outcome
Time
Sample
Population
Drug utilization
Accidents
Possible interactions
– NB alcohol, OCs, CAMs
Pregnancies
Deaths
Treatment failures
Note outcomes
– During pregnancy
– Of labour
– Of newborn infant
– Of breast-fed infant
Accurate timing
Adherence to instructions
Incorrect diagnosis
Batch
Resistance issue?